Quantitative proteomics reveals ELP2 as a regulator to the inhibitory effect of TNF-α on osteoblast differentiation

Journal of Proteomics

Volumn 114, Issue , 2015, Pages 234-246

  Xu, Chang Peng ^a,b   Li, Xue ^b,c   Hu, Yan Jun ^b   Cui, Zhuang ^b   Wang, Lei ^b   Liang, Liang ^b   Zhou, Yi Lin ^b   Yang, Ya Jun ^d   Yu, Bin ^b  

^a MEDICAL COLLEGE OF JINAN UNIVERSITY   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

^c GUANGZHOU UNIVERSITY OF CHINESE MEDICINE   (China)

^d GUANGDONG MEDICAL UNIVERSITY   (China)

Author keywords

ELP2; ITRAQ; MRM; Osteoblast differentiation; Quantitative proteomics; TNF

Indexed keywords

ADENOSINE TRIPHOSPHATASE INHIBITOR; BONE MORPHOGENETIC PROTEIN 2; CYTOCHROME B5; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; JANUS KINASE; MESSENGER RNA; NOTCH RECEPTOR; PROTEIN; PROTEIN ELP2; PROTEIN S 100; PROTEIN SERCA3; STAT PROTEIN; STAT3 PROTEIN; TRANSCRIPTION FACTOR RUNX2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; SIGNAL PEPTIDE; STATIP1 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; BONE REGENERATION; CELL DIFFERENTIATION; COLORIMETRY; CONTROLLED STUDY; DOWN REGULATION; ENERGY METABOLISM; FLUOROMETRY; GENE OVEREXPRESSION; LIQUID CHROMATOGRAPHY; MICROENVIRONMENT; MOLECULAR MECHANICS; MOUSE; NONHUMAN; OSTEOBLAST; PROTEIN ANALYSIS; PROTEIN DATABASE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEOMICS; QUANTITATIVE ANALYSIS; RNA INTERFERENCE; TANDEM MASS SPECTROMETRY; UPREGULATION; WESTERN BLOTTING; AMINO ACID SEQUENCE; ANIMAL; CELL CULTURE; CHEMISTRY; DRUG EFFECTS; INFLAMMATION; METABOLISM; MOLECULAR GENETICS; PATHOLOGY; PHYSIOLOGY; PROCEDURES; TUMOR MICROENVIRONMENT;

AMINO ACID SEQUENCE; ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; CELLULAR MICROENVIRONMENT; DOWN-REGULATION; INFLAMMATION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MOLECULAR SEQUENCE DATA; OSTEOBLASTS; PROTEIN INTERACTION MAPPING; PROTEOMICS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84919381275     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2014.11.002     Document Type: Article

References (35)

1. Li W., Yu B., Li M., Sun D., Hu Y., Zhao M., et al. NEMO-binding domain peptide promotes osteoblast differentiation impaired by tumor necrosis factor alpha. Biochem Biophys Res Commun 2010, 391(2):1228-1233.
2. Tang Y., Xie H., Chen J., Geng L., Chen H., Li X., et al. Activated NF-kappaB in bone marrow mesenchymal stem cells from systemic lupus erythematosus patients inhibits osteogenic differentiation through downregulating Smad signaling. Stem Cells Dev 2013, 22(4):668-678.
3. Tsialogiannis E., Polyzois I., Oak Tang Q., Pavlou G., Tsiridis E., Heliotis M., et al. Targeting bone morphogenetic protein antagonists: in vitro and in vivo evidence of their role in bone metabolism. Expert Opin Ther Targets 2009, 13(1):123-137.
4. Haversath M., Catelas I., Li X., Tassemeier T., Jager M. PGE(2) and BMP-2 in bone and cartilage metabolism: 2 intertwining pathways. Can J Physiol Pharmacol 2012, 90(11):1434-1445.
5. Kamiya N. The role of BMPs in bone anabolism and their potential targets SOST and DKK1. Curr Mol Pharmacol 2012, 5(2):153-163.
6. Kaneki H., Guo R., Chen D., Yao Z., Schwarz E.M., Zhang Y.E., et al. Tumor necrosis factor promotes Runx2 degradation through up-regulation of Smurf1 and Smurf2 in osteoblasts. J Biol Chem 2006, 281(7):4326-4333.
7. Yamazaki M., Fukushima H., Shin M., Katagiri T., Doi T., Takahashi T., et al. Tumor necrosis factor alpha represses bone morphogenetic protein (BMP) signaling by interfering with the DNA binding of Smads through the activation of NF-kappaB. J Biol Chem 2009, 284(51):35987-35995.
8. Lee H.L., Yi T., Woo K.M., Ryoo H.M., Kim G.S., Baek J.H. Msx2 mediates the inhibitory action of TNF-alpha on osteoblast differentiation. Exp Mol Med 2010, 42(6):437-445.
9. Yamashita M., Otsuka F., Mukai T., Otani H., Inagaki K., Miyoshi T., et al. Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway. J Endocrinol 2008, 196(3):601-613.
10. Mukai T., Otsuka F., Otani H., Yamashita M., Takasugi K., Inagaki K., et al. TNF-alpha inhibits BMP-induced osteoblast differentiation through activating SAPK/JNK signaling. Biochem Biophys Res Commun 2007, 356(4):1004-1010.
11. Takano M., Otsuka F., Matsumoto Y., Inagaki K., Takeda M., Nakamura E., et al. Peroxisome proliferator-activated receptor activity is involved in the osteoblastic differentiation regulated by bone morphogenetic proteins and tumor necrosis factor-alpha. Mol Cell Endocrinol 2012, 348(1):224-232.
12. Keshava Prasad T.S., Goel R., Kandasamy K., Keerthikumar S., Kumar S., Mathivanan S., et al. Human protein reference database-2009 update. Nucleic Acids Res 2009, 37:767-772.
13. Katagiri T., Yamaguchi A., Komaki M., Abe E., Takahashi N., Ikeda T., et al. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J Cell Biol 1994, 127(6 Pt 1):1755-1766.
14. Petriz B.A., Gomes C.P., Rocha L.A., Rezende T.M., Franco O.L. Proteomics applied to exercise physiology: a cutting-edge technology. J Cell Physiol 2012, 227(3):885-898.
15. Balakrishnan L., Bhattacharjee M., Ahmad S., Nirujogi R.S., Renuse S., Subbannayya Y., et al. Differential proteomic analysis of synovial fluid from rheumatoid arthritis and osteoarthritis patients. Clin Proteomics 2014, 11(1):1.
16. Chem Mead J.A., Bianco L., Bessant C. Mining proteomic MS/MS data for MRM transitions. Methods Mol Biol 2010, 604:187-199.
17. Zhang S., Wen B., Zhou B., Yang L., Cha C., Xu S., et al. Quantitative analysis of the human AKR family members in cancer cell lines using the mTRAQ/MRM approach. J Proteome Res 2013, 12(5):2022-2033.
18. Litvin J., Selim A.H., Montgomery M.O., Lehmann K., Rico M.C., Devlin H., et al. Expression and function of periostin-isoforms in bone. J Cell Biochem 2004, 92(5):1044-1061.
19. Pedrocchi M., Schafer B.W., Durussel I., Cox J.A., Heizmann C.W. Purification and characterization of the recombinant human calcium-binding S100 proteins CAPL and CACY. Biochemistry 1994, 33(21):6732-6738.
20. Duarte W.R., Shibata T., Takenaga K., Takahashi E., Kubota K., Ohya K., et al. S100A4: a novel negative regulator of mineralization and osteoblast differentiation. J Bone Miner Res 2003, 18(3):493-501.
21. Erlandsson M.C., Bian L., Jonsson I.M., Andersson K.M., Bokarewa M.I. Metastasin S100A4 is a mediator of sex hormone-dependent formation of the cortical bone. Mol Endocrinol 2013, 27(8):1311-1321.
22. 2+-ATPase (SERCA) 3 isoforms. Expression, regulation, and function of the membranes of the SERCA3 family. J Biol Chem 2002, 277(27):24442-24452.
23. 2+-ATPase 3 gene. J Biol Chem 2004, 279(23):24297-24306.
24. Bredoux R., Corvazier E., Dally S., Chaabane C., Bobe R., Raies A., et al. Human platelet Ca2+-ATPases: new markers of cell differentiation as illustrated in idiopathic scoliosis. Platelets 2006, 17(6):421-433.
25. Campanella M., Parker N., Tan C.H., Hall A.M., Duchen M.R. IF(1): setting the pace of the F(1)F(o)-ATP synthase. Trends Biochem Sci 2009, 34(7):343-350.
26. Shah D.I., Takahashi-Makise N., Cooney J.D., Li L., Schultz I.J., Pierce E.L., et al. Mitochondrial Atpif1 regulates haem synthesis in developing erythroblasts. Nature 2012, 491(7425):608-612.
27. Matsushita K., Itoh S., Ikeda S., Yamamoto Y., Yamauchi Y., Hayashi M. LIF/STAT3/SOCS3 signaling pathway in murine bone marrow stromal cells suppresses osteoblast differentiation. J Cell Biochem 2014, 115(7):1262-1268.
28. Peruzzi B., Cappariello A., Del Fattore A., Rucci N., De Benedetti F., Teti A. c-Src and IL-6 inhibit osteoblast differentiation and integrate IGFBP5 signalling. Nat Commun 2012, 3:630.
29. Hawkes N.A., Otero G., Winkler G.S., Marshall N., Dahmus M.E., Krappmann D., et al. Purification and characterization of the human elongator complex. J Biol Chem 2002, 277(4):3047-3052.
30. Kim J.H., Lane W.S., Reinberg D. Human elongator facilitates RNA polymerase II transcription through chromatin. Proc Natl Acad Sci U S A 2002, 99(3):1241-1246.
31. Meloche J., Courchesne A., Barrier M., Carter S., Bisserier M., Paulin R., et al. Critical role for the advanced glycation end-products receptor in pulmonary arterial hypertension etiology. J Am Heart Assoc 2013, 2(1):e5157.
32. Liu T., Li Y., Lin K., Yin H., He B., Zheng M., et al. Regulation of S100A4 expression via the JAK2-STAT3 pathway in rhomboid-phenotype pulmonary arterial smooth muscle cells exposure to hypoxia. Int J Biochem Cell Biol 2012, 44(8):1337-1345.
33. Pollack V., Sarkozi R., Banki Z., Feifel E., Wehn S., Gstraunthaler G., et al. Oncostatin M-induced effects on EMT in human proximal tubular cells: differential role of ERK signaling. Am J Physiol Renal Physiol 2007, 293(5):1714-1726.
34. Yoshimura A. Signal transduction of inflammatory cytokines and tumor development. Cancer Sci 2006, 97(6):439-447.
35. Singhatanadgit W., Salih V., Olsen I. Bone morphogenetic protein receptors and bone morphogenetic protein signaling are controlled by tumor necrosis factor-alpha in human bone cells. Int J Biochem Cell Biol 2006, 38(10):1794-1807.